Cargando…
Risk factors for sub–therapeutic serum concentrations of magnesium sulfate in severe preeclampsia of Chinese patients
BACKGROUND: Magnesium sulfate (MgSO(4)) is the standard drug for eclampsia prophylaxis and treatment. In China, the effective therapeutic serum magnesium level is 1.8–3.0 mmol/L. There is little information on how to achieve and maintain effective therapeutic concentrations. This study aimed to inve...
Autores principales: | Li, Jingjing, Tang, Lian, Tang, Ruiheng, Peng, Lan, Chai, Liqiang, Zhu, Liping, Yu, Yanxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528234/ https://www.ncbi.nlm.nih.gov/pubmed/33004015 http://dx.doi.org/10.1186/s12884-020-03277-0 |
Ejemplares similares
-
Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated Factors
por: da Costa, Tatiana Xavier, et al.
Publicado: (2020) -
Effect of Compound Danshen Injection Combined with Magnesium Sulfate on Oxidative Stress, TNF-α, NO, and Therapeutic Efficacy in Severe Preeclampsia
por: Zhou, Yanling, et al.
Publicado: (2022) -
Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia
por: Brookfield, Kathleen, et al.
Publicado: (2021) -
Effects of compound Danshen injection combined with magnesium sulfate on serum MPO and hs-CRP in patients with severe preeclampsia
por: Yang, Kun, et al.
Publicado: (2018) -
Clinical outcomes in neonates following maternal magnesium sulfate therapy in preeclampsia/eclampsia
por: Tikhova, G, et al.
Publicado: (2012)